Mettler-Toledo International, Inc. $MTD Position Lessened by Northwest & Ethical Investments L.P.

Key Points

• Northwest & Ethical Investments L.P. has reduced its stake in Mettler-Toledo International by 1.2%, owning 20,664 shares valued at approximately $24.4 million as of the latest SEC filing.
• Several research firms have recently changed their ratings on Mettler-Toledo International, with Wall Street Zen dropping the stock's rating from "buy" to "hold" while UBS upgraded it from "neutral" to "buy."
• Mettler-Toledo International reported earnings of $10.09 per share for the last quarter, exceeding analyst estimates, and a revenue of $983.22 million, marking a 3.9% increase year-over-year.

Northwest & Ethical Investments L.P. lessened its stake in Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 1.2% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 20,664 shares of the medical instruments supplier's stock after selling 242 shares during the quarter. Northwest & Ethical Investments L.P. owned 0.10% of Mettler-Toledo International worth $24,402,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. Greenleaf Trust lifted its position in Mettler-Toledo International by 1.2% during the first quarter. Greenleaf Trust now owns 872 shares of the medical instruments supplier's stock worth $1,030,000 after buying an additional 10 shares during the period. Sequoia Financial Advisors LLC increased its stake in Mettler-Toledo International by 1.8% during the first quarter. Sequoia Financial Advisors LLC now owns 627 shares of the medical instruments supplier's stock worth $740,000 after acquiring an additional 11 shares during the last quarter. Albion Financial Group UT grew its stake in shares of Mettler-Toledo International by 1.5% in the first quarter. Albion Financial Group UT now owns 754 shares of the medical instruments supplier's stock valued at $890,000 after buying an additional 11 shares in the last quarter. TD Private Client Wealth LLC grew its stake in shares of Mettler-Toledo International by 5.4% in the first quarter. TD Private Client Wealth LLC now owns 214 shares of the medical instruments supplier's stock valued at $253,000 after buying an additional 11 shares in the last quarter. Finally, Congress Asset Management Co. grew its stake in shares of Mettler-Toledo International by 1.8% in the first quarter. Congress Asset Management Co. now owns 667 shares of the medical instruments supplier's stock valued at $788,000 after buying an additional 12 shares in the last quarter. 95.07% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on the company. Bank of America raised their price objective on Mettler-Toledo International from $1,200.00 to $1,260.00 and gave the company a "neutral" rating in a research note on Thursday, June 26th. Jefferies Financial Group upgraded Mettler-Toledo International from an "underperform" rating to a "hold" rating and lowered their price objective for the company from $1,200.00 to $1,110.00 in a research note on Monday, May 5th. Robert W. Baird raised their price objective on Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the company a "neutral" rating in a research note on Monday, August 4th. Evercore ISI lowered their price objective on Mettler-Toledo International from $1,280.00 to $1,275.00 and set an "outperform" rating for the company in a research note on Monday, August 4th. Finally, UBS Group upgraded Mettler-Toledo International from a "neutral" rating to a "buy" rating and lowered their price objective for the company from $1,530.00 to $1,350.00 in a research note on Tuesday, May 20th. Five analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat.com, Mettler-Toledo International currently has a consensus rating of "Moderate Buy" and an average price target of $1,288.89.

Insider Transactions at Mettler-Toledo International

In related news, CFO Shawn Vadala sold 300 shares of the firm's stock in a transaction that occurred on Friday, August 8th. The stock was sold at an average price of $1,254.09, for a total value of $376,227.00. Following the sale, the chief financial officer owned 5,095 shares of the company's stock, valued at approximately $6,389,588.55. This trade represents a 5.56% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Thomas P. Salice sold 1,062 shares of the firm's stock in a transaction that occurred on Wednesday, August 13th. The stock was sold at an average price of $1,300.90, for a total value of $1,381,555.80. Following the completion of the sale, the director directly owned 283 shares in the company, valued at approximately $368,154.70. This trade represents a 78.96% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 2,589 shares of company stock worth $3,205,554. 1.94% of the stock is currently owned by corporate insiders.

Mettler-Toledo International Stock Down 0.7%

NYSE:MTD traded down $9.3230 during trading hours on Wednesday, reaching $1,313.2470. 211,145 shares of the stock were exchanged, compared to its average volume of 174,545. The firm has a 50 day simple moving average of $1,220.14 and a 200-day simple moving average of $1,188.83. Mettler-Toledo International, Inc. has a 52 week low of $946.69 and a 52 week high of $1,521.01. The stock has a market capitalization of $27.05 billion, a P/E ratio of 33.26, a P/E/G ratio of 3.94 and a beta of 1.34.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last released its earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 EPS for the quarter, topping analysts' consensus estimates of $9.58 by $0.51. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.The company had revenue of $983.22 million for the quarter, compared to the consensus estimate of $957.41 million. During the same quarter last year, the business posted $9.65 EPS. Mettler-Toledo International's quarterly revenue was up 3.9% compared to the same quarter last year. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. As a group, analysts expect that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current year.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.